Patient Controlled Intravenous Analgesia (PCiA) with the combination of morphine and S-ketamine.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27292

Enrollment

Registered

2010-12-28

Start date

2011-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia morfine S-ketamine nausea dreams hallucinations

Interventions

1. Preparation of the PCA syringes

2. Visit of the patient twice a day, three days long.

Eligibility

Inclusion criteria

Inclusion criteria: 1. 18 years and older; 2. Laparoscopic cholecystecomy.

Exclusion criteria

Exclusion criteria: hypertension recent myocardial infarction severe ischemic heart disease

Design outcomes

Primary

Measure	Time frame
1. Pain score (VAS); 2. Morphine used.	—

Secondary

Measure	Time frame
1. Nausea, vomiting; 2. Drowsiness; 3. Dreams, nightmares; 4. Hallucinations. Measurements as reported by patient.	—

Contacts

Public ContactC. Punt

Atrium Medisch Centrum P.O. Box 4446

cpt01@atriummc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)